Consumption of an oil composed of medium chain triacyglycerols. Phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight women

Metabolism: Clinical and Experimental

Volumn 52, Issue 6, 2003, Pages 771-777

  Bourque, Christine ^a,b   St Onge, Marie Pierre ^a,b   Papamandjaris, Andrea A ^a,b   Cohn, Jeffrey S ^a,b   Jones, Peter J H ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTHIOL; CHOLESTEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN TRIACYLGLYCEROL; OMEGA 3 FATTY ACID; PHYTOSTEROL; TRIACYLGLYCEROL; OIL;

ABDOMINAL DISCOMFORT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIET THERAPY; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; FOOD COMPOSITION; FOOD INTAKE; HOSPITAL PATIENT; HUMAN; LIPID BLOOD LEVEL; MEAT; NAUSEA; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHEMISTRY; DRUG COMBINATION; ENERGY METABOLISM; MIDDLE AGED;

ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; FEMALE; HOMOCYSTEINE; HUMANS; MIDDLE AGED; OBESITY; OILS; PHYTOSTEROLS; SINGLE-BLIND METHOD; TRIGLYCERIDES;

EID: 0038142242     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00070-2     Document Type: Article

References (51)

1. Heart and Stroke Foundation, Health Statistics, Division of Statistics Canada and Health Canada: Heart Disease and Stroke in Canada. Ottawa, ON, Canada, 1997
2. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute: Clinical Guidelines on the Identification, Evaluation, and the Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD, NIH Publication No. 98-4083, 1998
3. Scalfi L, Coltori A, Contaldo F: Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides. Am J Clin Nutr 53:1130-1133, 1991
4. Hill JO, Peters JC, Yang D, et al: Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism 38: 641-648, 1989
5. Dulloo AG, Fathi M, Mensi N, et al: Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides. A dose-response study in a human respiratory chamber. Eur J Clin Nutr 50:152-158, 1996
6. White MD, Papamandjaris AA, Jones PJH: Enhanced postprandial energy expenditure with medium-chain fatty acid feeding is attenuated after 14 d premenopausal women. Am J Clin Nutr 69;883-889, 1999
7. Swift LL, Hill JO, Peters JC, et al: Medium-chain fatty acids: Evidence for incorporation into chylomicron triglycerides in humans. Am J Clin Nutr 52:834-836, 1990
8. Johnson RC, Young SK, Cotter R, et al: Medium-chain-triglyceride lipid emulsion: Metabolism and tissue distribution. Am J Clin Nutr 52:502-508, 1990
9. DeLany JP, Windhauser MM, Champagne CM, et al: Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr 72:905-911, 2000
10. Carnielli VP, Sulkers EJ, Moretti KC, et al: Conversion of octanoic acid into long-chain saturated fatty acids in premature infants fed a formula containing medium-chain triglycerides. Metabolism 43: 1287-1292, 1994
11. Lavau MM, Hashim SA: Effect of medium chain triglyceride on lipogenesis and body fat in the rat. J Nutr 108:613-620, 1978
12. Geliebter A, Torbay N, Bracco EB, et al: Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. Am J Clin Nutr 37:1-4, 1983
13. Simon E, Fernandez-Quintela A, Del Puy Portillo M, et al: Effects of medium-chain fatty acids on body composition and protein metabolism in overweight rats. J Physiol Biochem 56:337-346, 2000
14. Tsuji H, Kasai M, Takeucchi H, et al: Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr 131:2853-2859, 2001
15. St-Onge M-P, Bourque C, Jones PJH, et al: Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes 27:95-102, 2003
16. Cater NB, Heller HJ, Denke MA: Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacyglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr 65:41-45, 1997
17. Tsai YH, Park S, Kovacic J, et al: Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acid. Lipids 34:895-905, 1999
18. Asakura L, Lottenberg AMP, Neves MQTS, et al: Dietary medium-chain triaglycerol prevents the postprandial rise of plasma triacyglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. Am J Clin Nutr 71:701-705, 2000
19. Temme EHM, Mensink RP, Hornstra G: Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects. J Lipid Res 38:1746-1754, 1997
20. Wardlaw GM, Snook JT, Park S, et al: Relative effects on serum lipids and apolipoproteins of a caprenin-rich diet compared with diets rich in palm oil/palm-kernel or butter. Am J Clin Nutr 61:535-542, 1995
21. Hill JO, Peters JC, Swift LL, et al: Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res 31:407-416, 1990
22. Swift LL, Hill JO, Peters JC, et al: Plasma lipids and lipoproteins during 6 d of maintenance feeding with long-chain, medium-chain, and mixed-chain triglycerides. Am J Clin Nutr 56:881-886, 1992
23. Jones PJ, MacDougall DE, Ntanios F, et al: Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 75:217-227, 1997
24. Miettinen TA, Puska P, Gylling H, et al: Reduction of serum cholesterol with sitostanol-ester margarine in a midly hypercholesterolemic population. N Engl J Med 333:1308-1312, 1995
25. Jones PJH, Ntanios FY, Raeini-Sarjaz M, et al: Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr 69:1144-1150, 1999
26. Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al: Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 41:697-705, 2000
27. Hendriks HFJ, Weststrate JA, Van Vliet T, et al: Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53:319-327, 1999
28. Pelletier X, Belbraouet S, Mirabel D, et al: A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab 39:291-295, 1995
29. Tammi A, Ronnemaa T, Gylling H, et al: Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: The STRIP project. J Pediatr 136: 503-510, 2000
30. Mantzioris E, James MJ, Gibson RA, et al: Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentanoic acid concentrations in tissues. Am J Clin Nutr 59:1304-1309, 1994
31. Layne KS, Goh YK, Jumpsen JA, et al: Normal subjects consuming physiological levels of 18: 3(n-3) and 20:5(n-3) from flaxseed or fish soils have characteristics differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 126:2130-2140, 1996
32. Cunnane SC, Ganguli S, Menard C, et al: High alpha-linolenic acid flaxseed (Linum usitatissimum): Some nutritional properties in humans. B J Nutr 69:443-453, 1993
33. Harris WS: n-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 65:1645S-16545S, 1997
34. Olszewski AJ, McCully KS: Fish oil decreases serum homocysteine in hyperlipemic men. Coron Artery Dis 4:53-60, 1993
35. Grundt H, Nilsen DW, Hetland O, et al: Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemost 81:561-565, 1999
36. Mifflin MD, St Jeor ST, Hill LA, et al: A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 51:241-247, 1990
37. Appendix A-11-e: Average daily energy requirement of adults whose occupational work is classified as light, moderate, or heavy, expressed as a multiple of basal metabolic rate, in Shils ME, Olson JA, Shike M, et al (eds): Modern Nutrition in Health and Disease (ed 9). Baltimore, MD, Williams & Wilkins, 1999
38. Health Canada: Recommended Nutrient Intakes for Canadians. Ottawa, Department of National Health and Welfare, 1990
39. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28:1379-1388, 1982
40. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
41. Durand P, Fortin LJ, Lussier-Cacan S, et al: Hyperhomocysteinemia induced by folic acid deficiency and methionine load - Applications of a modified HPLC method. Clin Chim Acta 252:83-93, 1996
42. Folch J, Lees M, Sloan S: A simple method for the isolation and purification of the total lipids animal tissues. J Biol Chem 226:497-509, 1957
43. Al Makdessi S, Andrieu JL, Bacconin A, et al: Assay of lipids in dog myocardium using capillary gas chromatography and derivatization with boron trifluoride and methanol. J Chromatogr 339:25-34, 1985
44. Jones PJH, Papamandjaris AA: Lipids: Cellular metabolism. In: Bowman BA, Russell RM, eds. Present Knowledge in Nutrition. ed 8. Washington, DC, ILSI, 2001, pp 104-114
45. Popkin BM, Siega-Riz AM, Haines PS, et al: Where's the fat? Trends in U.S. diets 1965-1996. Prev Med 32:245-254, 2001
46. The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction incidence of coronary heart disease to cholesterol lowering. JAMA 251:365-374, 1983
47. Pang D, Allman-Farinelli MA, Wong T, et al: Replacement of linoleic acid with alpha-linolenic acid does not alter blood lipids in normolipidaemic men. Br J Nutr 80:163-167, 1998
48. Goh YK, Jumpsen JA, Clandinin MT: Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia 40:45-52, 1997
49. Singer P, Berger I, Wirth M, et al: Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentanoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects. Prostaglandins Leukot Med 24:173-193, 1986
50. Indu M, Ghafoorunissa: N-3 fatty acids in Indian diets-comparison of the effects of precursor (alpha-linolenic acid) vs product (long chain n-3 polyunsaturated fatty acids). Nutr Res 12:569-582, 1992
51. Grimsgaard S, Bonaa KH, Hansen JB, et al: Highly purified eicosapentaenoic acid and docosahexeanoic acid in human have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 66:649-659, 1997